Pharmacokinetics and bioavailability of cefquinome in healthy piglets

Journal of Veterinary Pharmacology and Therapeutics

Volumn 31, Issue 6, 2008, Pages 523-527

  Li, X B ^a,b   Wu, W X ^b   Su, D ^b   Wang, Z J ^b   Jiang, H Y ^b   Shen, J Z ^b  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CEFQUINOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; COMPARTMENT MODEL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PIGLET; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CEPHALOSPORINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HALF-LIFE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; SWINE;

EID: 55949103779     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2008.00989.x     Document Type: Article

References (22)

1. Allan, M.J. Thomas, E. (2003) Pharmacokinetics of cefquinome after parenteral administration of an aqueous solution in the horse. Journal of Veterinary Pharmacology and Therapeutics, 26, 82 307.
2. Block, C.V., Wanner, M. Heinritzi, K. (2005) Pharmacokinetics of cephalosporine cefquinome in sows at different reproduction-phases. Tierarztliche Umschau, 60, 137 145.
3. Chen, K., Du, A.Q., Zhang, W., Qu, D.F. Zhan, Y.P. (2007) Identification and antimicrobial susceptibility of the Actinobacillus pleuropneumoniae isolates from Zibo. Shandong Journal of Animal Husbandry and Veterinary, 3, 11 12.
4. Chiers, K., Donne, E., Overbeke, I.V., Ducatelle, R. Haesebrouck, F. (2002) Actinobacillus pleuropneumoniae infections in closed swine herds: infection patterns and serological profiles. Veterinary Microbiology, 85, 343 352.
5. CVMP (1995) Cefquinome. Summary report. EMEA/MRL/005/95. European Agency for the Evaluation of Medicinal Products, London, UK.
6. CVMP (1999) Cefquinome (Extension to Pigs). Summary Report (2). EMEA/MRL/545/99-FINAL. European Agency for the Evaluation of Medicinal Products, London, UK.
7. Errecalde, C., Prieto, G., Puelles, I., Luders, C. Garcia Ovando, H. (2001) Plasma disposition of cefquinome in goats after intramuscular application. Investigation Veterinaria, 3, 89 94.
8. Gibaldi, M. Perrier, D. (1982) Pharmacokinetics, 2nd edn., Marcel Dekker Inc., New York.
9. Gutiérrez-Martín, C.B., del Blanco, N.G., Blanco, M., Navas, J. Rodríguez-Ferri, E.F. (2006) Changes in antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Spain during the last decade. Veterinary Microbiology, 115, 218 222.
10. Losinger, W.C. (2005) Economic impacts of reduced pork production associated with the diagnosis of Actinobacillus pleuropneumoniae on grower/finisher swine operations in the United States. Preventive Veterinary Medicine, 68, 181 193.
11. Maes, A., Meyns, T., Sustronck, B., Maes, D., De Backer, P. Croubels, S. (2007) Determination of cefquinome in pig plasma and bronchoalveolar lavage fluid by high-performance liquid chromatography combined with electrospray ionization mass spectrometry. Journal of Mass Spectrometry and Ion Physics, 42, 657 663.
12. Matter, D., Rossano, A., Limat, S., Vorlet Fawer, L., Brodard, I. Perreten, V. (2007) Antimicrobial resistance profile of Actinobacillus pleuropneumoniae and Actinobacillus porcitonsillarum. Veterinary Microbiology 122, 146 156.
13. Meiging, L. Fubao, L. (2007) Diagnosis and treatment of acute contagious pleuropneumoniae of piglets. Modern Agricultural Science and Technology, 3, 118, 126.
14. Michael, L., Dieter, I., Norbert, K., Astrid, M., Karl, S., Gerhard, S. Elmar, S. (1991) Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111v), a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy, 30, 14 19.
15. Nicolet, J. (1992) Actinobacillus pleuropneumoniae. In Actinobacillus Pleuropneumoniae, Diseases of Swine. Eds Leman, A.D., Straw, B., Mengeling, W.L., D' Allaire, S. Taylor, P.D.J., pp. 401 408. Iowa State University Press, Ames, IA.
16. Rassbach, A. Schimmel, D. (1996) Efficacy of cefquinome against experimental Haemophilus parasuis infection in primary SPF piglets. Tierarztliche Umschau, 51, 398 400, 402.
17. Schimmel, D., Erler, W., Seeger, K., Schorning, S. Humke, R. (1990) In vitro and in vivo efficacy of cobactan on respiratory diseases agents. Proceedings of the 11th International Pig Veterinary Society Congress, 101 pp., Lausanne, Switzerland.
18. Shen, J.Z., Xiubo, L., Jiang, H.Y. Walter, H.H. (2004) Bioavailability and pharmacokinetics of florfenicol in healthy sheep. Journal of Veterinary Pharmacology and Therapeutics, 27, 163 168.
19. Taylor, D. (1999) Actinobacillus pleuropneumoniae. In Diseases of swine, 8th edn. Eds Straw, B., D' Allaire, S., Mengeling, W. Taylor, D., pp 343 354. Iowa State University Press, Ames, IA.
20. Thomas, E., Thomas, V. Wilhelm, C. (2006) Antibacterial activity of cefquinome against equine bacterial pathogens. Veterinary Microbiology, 115, 140 147.
21. Yamaoka, K., Nakagawa, T. Uno, T. (1978) Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Biochemistry, 100, 609 618.
22. Yoshimura, H., Takagi, M., Ishimura, M. Endoh, Y.S. (2002) Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae. Veterinary Research Communications, 26, 11 19.